The better understanding of the biological behavior of multiple endocrine neoplasia type 1
(MEN1) organ manifestations and the increase in clinical experience warrant a revision of …

Chronic diarrhea is a common problem affecting up to 5% of the population at a given time.
Patients vary in their definition of diarrhea, citing loose stool consistency, increased …

Neuroendocrine gastroenteropancreatic tumors (GEP-NETs) constitute a heterogeneous
group of tumors with their origin in neuroendocrine cells of the embryological gut. Most …

Gastrinomas are neuroendocrine neoplasms, usually located in the duodenum or pancreas,
that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome …

Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show characteristic clinical, histomorphologic, and …

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2
major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the …

Pancreatic endocrine tumors (PETs) have long fascinated clinicians and investigators
despite their relative rarity. Their clinical presentation varies depending on whether the …

Neuroendocrine tumors (NETs) are rare, slow-growing neo-plasms characterized by their
ability to store and secrete different peptides and neuroamines. 1 Some of these substances …

Neuroendocrine neoplasms (NENs) are heterogeneous tumours with a common phenotype
descended from the diffuse endocrine system. NENs are found nearly anywhere in the body …

Pancreatic endocrine tumors have been steadily growing in incidence and prevalence
during the last two decades, showing an incidence of 4–5/1,000,000 population. They …